comparemela.com

Latest Breaking News On - China medical system holdings limited - Page 2 : comparemela.com

China Medical System: New Drug Application of Desidustat

SHENZHEN, CHINA, April 23, 2024 (GLOBE NEWSWIRE) Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney.

China
Shenzhen
Guangdong
India
Chinese
Cadila-healthcare
China-medical-system-holdings-limited
National-medical-products-administration-of-china
China-medical-system-holdings-ltd
Zydus-lifesciences
Desidustat-tablets


acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Shenzhen
Guangdong
China
India
Chinese
National-medical-products-administration-of-china
China-medical-system-holdings-limited
China-medical-system-holdings-ltd
Cadila-healthcare
Zydus-lifesciences
China-medical-system-holdings

China Medical System: New Drug Application of Desidustat Tablets Accepted in China

China Medical System: New Drug Application of Desidustat Tablets Accepted in China
asiaone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaone.com Daily Mail and Mail on Sunday newspapers.

China
India
Shenzhen
Guangdong
Chinese
Cadila-healthcare
National-medical-products-administration-of-china
China-medical-system-holdings-ltd
China-medical-system-holdings-limited
Zydus-lifesciences
Desidustat-tablets


acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
China
Taiwan
Hong-kong
Indonesia
Thailand
Vietnam
Republic-of
Macau
Singapore
Delaware
Macao

Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia

Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Taiwan
Thailand
Singapore
Malaysia
Indonesia
Vietnam
Republic-of
Macau
Macao
Macau-general
China
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.